Literature DB >> 6091864

Large cell carcinoma of the lung associated with marked eosinophilia. A case report.

T Kodama, K Takada, T Kameya, Y Shimosato, R Tsuchiya, T Okabe.   

Abstract

A case of large cell carcinoma of the lung which produced eosinophil colony stimulating factor and eosinophil chemotactic factor was reported. A 52-year-old Japanese man with a tumor in the left upper lobe of the lung underwent left pneumonectomy. Marked eosinophilia persisted especially after recurrence, with a maximum peripheral leukocyte count of 161,000/mm3, of which 78% consisted of eosinophils. The patient died of pulmonary insufficiency 18 months after surgery. At autopsy, metastatic tumor tissues and almost all organs were markedly infiltrated with eosinophils, especially the spleen, and there was marked proliferation of eosinophils in the bone marrow. Eosinophil colony stimulating factor production by the transplanted tumor in a nude mouse was confirmed by use of a human bone marrow culture assay system. Eosinophil chemotactic factor production by metastatic tumor tissue also was proved by a modified micro-filter technique.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091864     DOI: 10.1002/1097-0142(19841115)54:10<2313::aid-cncr2820541044>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Hypereosinophilia and metastatic anaplastic carcinoma of unknown primary.

Authors:  H Abali; M K Altundag; H Engin; O O Altundag; A Türker; A Uner; S Ruacan
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

2.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Metastatic Lung Adenocarcinoma Presenting with Hypereosinophilia.

Authors:  Omar Abughanimeh; Mohammad Tahboub; Mouhanna Abu Ghanimeh
Journal:  Cureus       Date:  2018-06-22

4.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

5.  Hypereosinophilia in Solid Tumors-Case Report and Clinical Review.

Authors:  Ewa Zalewska; Łukasz Obołończyk; Krzysztof Sworczak
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

6.  Adenosquamous carcinoma of the uterine cervix displaying tumor-associated tissue eosinophilia.

Authors:  Nozomu Kurose; Seiya Mizuguchi; Yoshiiku Ohkanemasa; Manabu Yamashita; Mariko Nakano; Xin Guo; Akane Aikawa; Satoko Nakada; Toshiyuki Sasagawa; Sohsuke Yamada
Journal:  SAGE Open Med Case Rep       Date:  2019-02-13

7.  Tumor-associated eosinophilia in a patient with EGFR-positive, MET-amplified lung adenocarcinoma refractory to targeted therapy: a case report and review of literature.

Authors:  Nan Geng; Wenxia Hu; Hui Ge; Shaonan Xie; Cuimin Ding
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.